Concern at drug pricing plans

Prices of branded drugs will be tackled so their cost matches the value they offer to patients, the government has said.

Drug price could link to value (Photograph: SPL)

The coalition's 'programme for government' pledges to 'reform NICE and move to a system of value-based pricing, so that all patients can access the drugs and treatments their doctors think they need'.

The Conservative party has previously suggested that NICE could be involved in price discussions and that, if treatments are not deemed cost-effective, the NHS would only pay for treatments shown to work in particular patients.

Professor Karol Sikora of pharmaceutical consultancy TranScrip Partners said policies on value-based pricing would need to be considered carefully.

'It is hard to see how the NHS will be an attractive customer to the global pharmaceutical industry if selling to it requires fulfilling a bureaucratic procurement process,' he said.

Dr Sarah Wilson of the University of Central Lancashire, an expert in the ethics of healthcare provision, said the way value-based pricing was being presented implied decisions about which medicines are available to patients could be made on a case-by-case basis, ignoring the wider economic context.

NICE said it looked forward to seeing the detail of the government's proposals and would happily work with it to 'secure high quality, good value health and social care'.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Follow Us:

Just published

NHS prescription and packet of pills

GPs can now prescribe flu antivirals on the NHS

GPs and other prescribers are now able to issue NHS prescriptions for antivirals...

GP sign

Prevention set to be key battleground for 2024 GP contract

Negotiations on a new GP contract from 2024/25 will need to 'align closely' with...

Talking General Practice logo

Podcast: What makes a strong PCN and how will integrated care systems affect networks?

Talking General Practice speaks to GP and PCN clinical director Professor Aruna Garcea,...


GP core funding rise outstripped by staff pay awards under five-year contract

Staff pay awards have outstripped increases in core GP practice funding between 2019/20...

BMA sign

Fifth of GP time spent on non-medical work as NHS absorbs cost of 'government failure'

Doctors are 'picking up the pieces of government failures' as the cost-of-living...


How the five fundamentals of COPD care can help GPs support patients

GP Dr Andrew Whittamore, clinical lead at Asthma + Lung UK, explains NICE’s five...